Trung Huynh
Stock Analyst at UBS
(2.17)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
JSPR Jasper Therapeutics | Maintains: Buy | 29 25 | 2.62 | 854.2% | 3 | Aug 15, 2025 | |
INSM Insmed | Maintains: Strong Buy | 133 140 | 112.87 | 24.04% | 7 | Aug 13, 2025 | |
LLY Eli Lilly | Maintains: Buy | 1050 895 | 635.48 | 40.84% | 9 | Aug 8, 2025 | |
AMGN Amgen | Maintains: Neutral | 326 317 | 285.1 | 11.19% | 6 | Aug 6, 2025 | |
REGN Regeneron Pharmaceut... | Maintains: Neutral | 560 584 | 546.18 | 6.92% | 4 | Jul 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 44 38 | 20.01 | 89.91% | 2 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 24 25 | 24.61 | 1.58% | 6 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 60 54 | 45.94 | 17.54% | 5 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 7 | 1.32 | 430.3% | 2 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 13 | 3.08 | 322.08% | 1 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 170 175 | 173.87 | 0.65% | 2 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 125 126 | 80.06 | 57.38% | 3 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 170 | 198.62 | -14.41% | 1 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 1 | Mar 23, 2021 |